Moodys and S&P go beyond financial metrics on acquisitions.

Drugmaker wants more flexibility to sell assets.

Drugmaker wants more flexibility to sell assets.

Drugmaker already convinced its lenders to relax interest-coverage term in April.

Drugmaker already convinced its lenders to relax interest-coverage term in April.

Cash coverage for near-term maturities is at lowest level since 2011, Moody's says.

What happens when debt markets lose confidence in a company's bonds.

What happens when debt markets lose confidence in a company's bonds.